Jan 29 (Reuters) - Aspen Pharmacare Holdings Ltd:
* STRATEGIC REVIEW OF ASPEN’S GLOBAL NUTRITIONALS BUSINESS * ‍HAS BEEN EXPLORING OPTIONS TO ENHANCE VALUE OF ITS GLOBAL NUTRITIONALS BUSINESS (“NUTRITIONALS”) SINCE RECEIVING AN UNSOLICITED APPROACH IN Q3 OF LAST YEAR​
* ‍CFDA OF REGISTRATION OF ASPEN‘S INFANT MILK FORMULA BRAND, ALULA, ASPEN HAS DECIDED TO FORMALISE ITS REVIEW OF STRATEGIC OPTIONS FOR NUTRITIONALS​
* ‍RANGE OF OPTIONS WILL BE CONSIDERED INCLUDING, INTER ALIA, INTRODUCTION OF A STRATEGIC PARTNER THAT COULD UNLOCK APPROPRIATE VALUE​
* ‍APPOINTED CENTERVIEW PARTNERS UK LLP AS FINANCIAL ADVISOR TO ASSIST IN STRATEGIC REVIEW PROCESS​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)
 